Regional Medical Center

Details Contact
Medical Suppliers In Florida

Name :

Regional Medical Center

Address  :

14000 Fivay Road

Town  :

Hudson

State  :

Florida

Country  :

USA

Post Code:

34667

Phone  :

727 819 2929

Fax  :

727 868 6431

Web URL  :

Available
Specialization
Information not available, if you are owner/employee of Regional Medical Center Please click to update hospital details.
Facilities

Total Number Of Beds : 290

Description
About Us
Regional Medical Center Bayonet Point is a 290bed acute care facility located in Hudson Florida Home of the nationally acclaimed Heart Institute over 350 physicians 950 employees and 500 volunteers comprise our integrated healthcare delivery team

Our nationally recognized Heart Institute Accredited Stroke Center Accredited Chest Pain Center Commission on Cancer approved Cancer Care Orthopedic and Neurosurgery programs are all examples of the high quality results we produce while caring for our patients We provide a full range of adult cardiac services and our physicians are dedicated to the diagnosis treatment and prevention of heart disease We provide comprehensive cardiac service and have performed over 100000 procedures since opening our doors

The experienced nurses technicians therapists dieticians and chaplains on our staff contribute to this commitment to excellence This multifaceted team of healthcare professionals have contributed to our ongoing history of quality performances as evidenced by the following awards in the past years
NEWS
Urine Odor Signals UTI in Infants

Reviewed by Zalman S Agus MD Emeritus Professor Perelman School of Medicine at the University of Pennsylvania and Dorothy Caputo MA RN BCADM Nurse Planner Badsmelling urine is a good predictor of urinary tract infection UTI in infants better than several other associated predictors researchers found Though malodorous urine did not definitive... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More